AfricaRegulatory

African Pharmaceutical Regulatory Intelligence

ENOXAPARINE SODIQUE

25 registrations across 3 African markets— 25 active

Markets with ENOXAPARINE SODIQUE

Recent registrations

Brand / ProductMarketHolderStatusExpires
ENOXAPARINE SODIQUE 40MG/0.4ML SI SC/IV BTE(2SER PR X
Solution injectable en
🇲🇬MadagascarEXETER HEALTH LIMITEDactive
ENOXAGEN
solution injectable en seringue pré-remplie / 6000 ui/0,6 ml
🇸🇳SenegalGENERIC HEALTHCARE PVT.LTDactive
ENOXA® 6000 UI ANTI-XA/0,6ML SI SC/INTRAVASC BTE (2 SER
Solution injectable, Boîte de 2
🇲🇬MadagascarLABORATOIRES MEDIS S.A.active
ENOXAPARINE CRUSIA® 4000 UI (40 MG) / 0,4 ML SI SER PRE
solution injectable en seringue
🇲🇬MadagascarLABORATORIOSactive
ENOXAPARINE CRUSIA® 2000 UI (20 MG) / 0,2 ML SI SER PRE
solution injectable en seringue
🇲🇬MadagascarLABORATORIOSactive
LOVENOX 8000UI ANTI-XA 0,8ML SI SPR(2) SANOFI-AVENTIS France
solution injectable en seringue
🇲🇬MadagascarSANOFI WINTHROP INDUSTRIE,,active
LOVENOX 6000UI ANTI-XA/0,6ML SI SPR (2) SANOFI-AVENTIS
solution injectable en seringue
🇲🇬MadagascarSANOFI WINTHROP INDUSTRIE,,active
GHEMAXAN 2.000 UI (20 MG) / 0,2 ML SOLUTION INJECTABLE EN SC/ IV, SERINGUE PREREMPLIE, BOITE DE 10🇨🇮Côte d'IvoireCHEMI S.p.Aactive
GHEMAXAN 6000 UI (20 MG) / 0,2 ML SOLUTION INJECTABLE EN SC/ IV, SERINGUE PREREMPLIE, BOITE DE 10🇨🇮Côte d'IvoireCHEMI S.p.Aactive
GHEMAXAN 8000 UI (20 MG) / 0,2 ML SOLUTION INJECTABLE EN SC/ IV, SERINGUE PREREMPLIE, BOITE DE 10🇨🇮Côte d'IvoireCHEMI S.p.Aactive
GHEMAXAN 4000 UI (20 MG) / 0,2 ML SOLUTION INJECTABLE EN SC/ IV, SERINGUE PREREMPLIE, BOITE DE 10🇨🇮Côte d'IvoireCHEMI S.p.Aactive
ENOXAGEN
solution injectable en seringue pré-remplie / 4000 ui/0,4 ml
🇸🇳SenegalGENERIC HEALTHCARE PVT.LTDactive
ENOXAMED
solution injectable en seringue pré-remplie / 6000 ui/0,4 ml
🇸🇳SenegalUNIMEDactive
ENOXA® 4000 UI ANTI-XA/0,4ML SI SC/INTRAVASC BTE (2 SER
Solution injectable, Boîte de 2
🇲🇬MadagascarLABORATOIRES MEDIS S.A.active
ENOXA® 6000 UI ANTI-XA/0,6ML SI SC/INTRAVASC BTE (2 SER
Solution injectable, Boîte de 2
🇲🇬MadagascarLABORATOIRES MEDIS S.A.active
ENOXAPARINE CRUSIA® 2000 UI (20 MG) / 0,2 ML SI SER PRE
solution injectable en seringue
🇲🇬MadagascarLABORATORIOSactive
ENOXAPARINE CRUSIA® 4000 UI (40 MG) / 0,4 ML SI SER PRE
solution injectable en seringue
🇲🇬MadagascarLABORATORIOSactive
ENOXAPARINE CRUSIA® 6000 UI (60 MG) / 0,6 ML SI SER PRE
solution injectable en seringue
🇲🇬MadagascarLABORATORIOSactive
ENOXAPARINE CRUSIA® 8000 UI (80 MG) / 0,8 ML SI SER PRE
solution injectable en seringue
🇲🇬MadagascarLABORATORIOSactive
ENOXAPARINE SODIQUE 40MG/0.4ML SI SC/IV BTE(2SER PR X
Solution injectable en
🇲🇬MadagascarEXETER HEALTH LIMITEDactive
LOVENOX 6000UI ANTI-XA/0,6ML SI SPR (2) SANOFI-AVENTIS
solution injectable en seringue
🇲🇬MadagascarSANOFI WINTHROP INDUSTRIE,,active
LOVENOX 8000UI ANTI-XA 0,8ML SI SPR(2) SANOFI-AVENTIS France
solution injectable en seringue
🇲🇬MadagascarSANOFI WINTHROP INDUSTRIE,,active
ENOXA® 4000 UI ANTI-XA/0,4ML SI SC/INTRAVASC BTE (2 SER
Solution injectable, Boîte de 2
🇲🇬MadagascarLABORATOIRES MEDIS S.A.active
ENOXAPARINE CRUSIA® 6000 UI (60 MG) / 0,6 ML SI SER PRE
solution injectable en seringue
🇲🇬MadagascarLABORATORIOSactive
ENOXAPARINE CRUSIA® 8000 UI (80 MG) / 0,8 ML SI SER PRE
solution injectable en seringue
🇲🇬MadagascarLABORATORIOSactive

ENOXAPARINE SODIQUE in Africa — Regulatory Overview

ENOXAPARINE SODIQUE is registered across 3 African markets with 25 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Madagascar, Côte d'Ivoire, Senegal. AfricaRegulatory refreshes this data daily from official government sources.

Of the 25 registrations, 25 (100%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.